Vendor, Durham, NC
Biocryst Pharmaceuticals Inc.
UEI MGXADJ6SCLJ5, CAGE 4GBX7
18 awards and -$26,127,043 obligated between February 16, 2024 and September 3, 2026, 100% under full and open competition, against 58.0 offers on average where reported. 3 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Department of Veterans Affairs | $2,162,057 |
| National Institutes of Health | -$3,711,828 |
| Office of Assistant Secretary for Preparedness and Response | -$24,577,272 |
Industries
NAICS on the awards, by dollars.
| Pharmaceutical Preparation ManufacturingNAICS 325412 | $16,039,731 |
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | -$3,711,828 |
| Professional, Scientific, and Technical ServicesNAICS 541711 | -$8,587,497 |
| Professional, Scientific, and Technical ServicesNAICS 541710 | -$29,867,448 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 18 |
| Delivery Order | 12 |
| Definitive Contract | 3 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Peramivir (RAPIVAB (peramivir injection)
Office of Assistant Secretary for Preparedness and Response, Aspr/Orm-Sns
JustificationNAICS 325412Durham, NC75A50324F80012-LSJAwarded to Biocryst Pharmaceuticals Inc.
Posted Sep 25, 2024 - Peramivir (RAPIVAB (peramivir injection)
Office of Assistant Secretary for Preparedness and Response, Aspr/Orm-Sns
Award noticeNAICS 325412Durham, NC75A50324Q00006Awarded to Biocryst Pharmaceuticals Inc. for $69,388,369
Posted Sep 25, 20242 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50324F80012Delivery Order, September 23, 2024, Full and Open Competition, 1 offersSolicitation | Aspr/Orm-SnsOffice of Assistant Secretary for Preparedness and Response | Peramivir (Rapivab 200mg/20ml (10mg/Ml Inj Soln))NAICS 325412, PSC 6505 | $13,877,674 |
| 36C26025F0024Delivery Order, October 1, 2024, Full and Open Competition, 1 offers | 260-Network Contract Office 20Department of Veterans Affairs | Berotralstat HCL 150MG Cap,oral (Orladeyo).NAICS 325412, PSC 6505 | $379,939 |
| 36C26024F0625Delivery Order, September 9, 2024, Full and Open Competition, 1 offers | 260-Network Contract Office 20Department of Veterans Affairs | Berotralstat HCL 150MG Cap,oral Trade Name: Orladeyo 150MG CapNAICS 325412, PSC 6505 | $379,349 |
| 36C26026F0006Delivery Order, October 1, 2025, Full and Open Competition, 1 offers | 260-Network Contract Office 20Department of Veterans Affairs | Pharm - OrladeyoNAICS 325412, PSC 6505 | $360,000 |
| 36C26024F0270Delivery Order, March 12, 2024, Full and Open Competition, 1 offers | 260-Network Contract Office 20Department of Veterans Affairs | Bulk Order OrladeyoNAICS 325412, PSC 6505 | $357,245 |
| 36C26025F0070Delivery Order, November 4, 2024, Full and Open Competition, 1 offers | 260-Network Contract Office 20Department of Veterans Affairs | Bulk Orladeyo PharmaceuticalNAICS 325412, PSC 6505 | $242,987 |
| 36C26024F0258Delivery Order, March 1, 2024, Full and Open Competition, 1 offers | 260-Network Contract Office 20Department of Veterans Affairs | Orladeyo 150MG CapsNAICS 325412, PSC 6505 | $201,722 |
| 36C26026F0294Delivery Order, May 19, 2026, Full and Open Competition, 1 offers | 260-Network Contract Office 20Department of Veterans Affairs | Orladeyo 150MG CapNAICS 325412, PSC 6505 | $151,465 |
| 36C24926F0152Delivery Order, May 21, 2026, Full and Open Competition, 1 offers | 249-Network Contract Office 9Department of Veterans Affairs | Emergency OrladeyoNAICS 325412, PSC 6505 | $30,293 |
| 36C26024F0240Delivery Order, February 20, 2024, Full and Open Competition, 1 offers | 260-Network Contract Office 20Department of Veterans Affairs | Orladeyo EmergentNAICS 325412, PSC 6505 | $29,650 |
| 36C26025F0296Delivery Order, June 18, 2025, Full and Open Competition, 1 offers | 260-Network Contract Office 20Department of Veterans Affairs | Bulk Order Orladeyo for Veteran Care.NAICS 325412, PSC 6505 | $29,408 |
| 36C26124N0446Delivery Order, February 16, 2024, Full and Open Competition, 1 offers | 261-Network Contract Office 21Department of Veterans Affairs | BerotralstatNAICS 325412, PSC 6505 | $0 |
| 36E79721A0015April 17, 2024, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Exercise Option Year 3NAICS 325412, PSC 6505 | $0 |
| 36E79726A0015June 2, 2026, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | BPA for Orladeyo and RapivabNAICS 325412, PSC 6505 | $0 |
| 36F79721D0166November 21, 2024, Full and Open Competition, 999 offersSolicitation | Nac Federal Supply ScheduleDepartment of Veterans Affairs | Public Law 2025NAICS 325412, PSC 6505 | $0 |
| 75N93020C00055Definitive Contract, August 19, 2024, Full and Open Competition, 23 offers | National Institutes of Health NiaidNational Institutes of Health | Extend Period of Performance for the Base Till September 30, 2022. (Note: the Modification P00003 Is Modification P00002 in the NBS System, NAICS 541715, PSC AJ12 | -$3,711,828 |
| HHSO100201500007CDefinitive Contract, August 13, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | De-Obligate Canceling Funds.NAICS 541711, PSC AN13 | -$8,587,497 |
| HHSO100200700032CDefinitive Contract, December 31, 2024, Full and Open Competition, 7 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Modification 12NAICS 541710, PSC AN13 | -$29,867,448 |
- Places of performance
- MissouriNorth CarolinaAlabama
- Product and service codes
- 6505 Drugs and BiologicalsAJ12 General Science And Technology R&D Services; General Science And Technology; Applied ResearchAN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 40 across 18 awards